{"version":"1.0","type":"link","title":"Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.","author_name":"Cooper BT 외","author_url":"https://prs-insight.online/author/Cooper%20BT","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/100894","thumbnail_width":1200,"thumbnail_height":630}